![Concarlo holdings llc](/api/images/company-pic/0-1574558-company.png)
Contattaci
Circa la società
Concarlo Holdings focuses on developing solutions for drug-resistant breast cancer. Its technologies, including IpY, a cdk inhibitor, as well as ApY, an antibody focus on increasing drug efficacy and diagnostic evaluations for ER/PR+ Her 2- patients.
US
Sconosciuto
Azienda non verificata
Trasparenza aziendale
- Informazioni sull'azienda non verificate
- Chiedi ai loro clienti per le recensioni
- Non ha risposto alle recensioni negative